Bicara Therapeutics (BCAX) vs Janux Therapeutics (JANX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bicara Therapeutics (BCAX) has outperformed Janux Therapeutics (JANX) over the past year, losing 9.6% versus a loss of 21.0%. Janux Therapeutics is the larger company by market cap ($1.10 billion vs $1.09 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCAX | JANX |
|---|---|---|
| Share price | $16.42 | $17.92 |
| Market cap | $1.09B | $1.10B |
| 1-day change | -0.85% | +6.73% |
| YTD return | -2.44% | +29.86% |
| 1-year return | -9.63% | -21.02% |
| 5-year return | — | -15.19% |
| EPS (TTM) | $-3.05 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.99 | $35.34 |
| 52-week low | $13.70 | $12.12 |
| Distance from 52-week high | -47.02% | -49.29% |
| Average volume | 605.61K | 830.67K |
| Shares outstanding | 66.17M | 61.14M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BCAX has outperformed JANX by 11.4 percentage points over the past year.
BCAX vs JANX FAQ
Which is bigger, Bicara Therapeutics or Janux Therapeutics?
Janux Therapeutics (JANX) is larger, with a market capitalization of $1.10B compared with $1.09B for Bicara Therapeutics (BCAX).
Which stock has performed better over the past year, BCAX or JANX?
BCAX returned -9.63% over the past 12 months, compared with -21.02% for JANX (price return, excluding dividends). Past performance does not predict future results.
Are Bicara Therapeutics and Janux Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.